PNC Financial Services Group’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4
Closed -$960 4785
2022
Q4
$960 Hold
4
﹤0.01% 4417
2022
Q3
$2K Hold
4
﹤0.01% 4200
2022
Q2
$2K Hold
4
﹤0.01% 4229
2022
Q1
$3K Hold
4
﹤0.01% 4121
2021
Q4
$5K Sell
4
-1
-20% -$2.17K ﹤0.01% 3981
2021
Q3
$19K Buy
+5
New +$15.8K ﹤0.01% 3527
2018
Q4
Sell
-2
Closed -$1K 4141
2018
Q3
$1K Buy
+2
New +$1.22K ﹤0.01% 4052

Other funds holding PAVM

PNC Financial Services Group's PAVM Position: Q1 2023 in Review

PNC Financial Services Group sold out of PAVmed (PAVM) in Q1 2023, closing a stake of 4 shares — an estimated $960 sold.

PNC Financial Services Group first reported a position in PAVM in Q3 2018 and held it in 7 quarters. The position peaked at $19K in Q3 2021. 58 funds tracked by Wall St. Rank hold PAVM as of Q1 2023.

  • PNC Financial Services Group reported no remaining PAVmed position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 4 PAVmed shares in Q1 2023, an estimated $960.
  • PNC Financial Services Group first reported a position in PAVmed in Q3 2018 and held it in 7 quarters.
  • PNC Financial Services Group's PAVmed position peaked at $19K in Q3 2021.
  • 58 funds tracked by Wall St. Rank held PAVmed as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.